Patient case (clinical description): A 2-year-old boy is brought to the office by his parents due to a rash that started 1 week ago.  A similar red, itchy rash on the cheeks, trunk, and arms has occurred intermittently since infancy.  The patient has had a few upper respiratory infections but no major illnesses.  Vaccinations are up to date, and he takes no medications. He is on a balanced diet, and he is healthy in appearance.  Vital signs and milestone examination are within normal limits.  Similar findings are observed on the cheeks and proximal upper extremities.  The diaper area is clear, and no mucosal lesions are present.

Patient's own account: I just brought my two-year-old son to the doctor's office because he had a rash for like one week. His rash was on the cheeks, the trunk, and his arms. He already had this before, and it keeps coming back from time to time to time. In the past, he had some respiratory infections but he has never been this sick. His vaccinations are up to date, and he doesn't take any medication. He's healthy with a nice diet. The doctor told me his vitals and milestone examinations were normal. The doctor also said there was a rash around the cheek and the upper part of his arms. The diaper area is okay, and there are no lesions.

Clinical trial: Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Eligibility criteria:
Inclusion Criteria:

          -  • Male or female between 2 and 12 years of age

               -  The subject suffers from moderate atopic dermatitis (SCORAD<40) that is amenable
                  to treatment

               -  Diagnosis of atopic dermatitis meets Hanifin's criteria (at least 3 basic
                  features and at least 3 minor features)

               -  Atopic dermatitis is, in the opinion of the investigator, stable for the past 7
                  days

               -  The subject's parents are able to apply the study product twice a day (each
                  morning and evening) for a consecutive period of 42 days

               -  The subject's parents agree that the subject will not change his/her lifestyle
                  during the study period (including: regular body hygiene product (soap), the
                  number of baths and showers per day, the laundry detergent and fabric softener
                  used to wash clothes)

               -  The subject's parents agree to use only the test product during the study period

               -  The subject's legal guardian is able and willing to sign the informed consent
                  form and to comply with the study regulations of this protocol

        Exclusion Criteria:

          -  • The subject has another dermatological disease/condition that could interfere with
             the clinical evaluation, including infected atopic dermatitis lesions

               -  The subject has a previous history of allergy to cosmetic products or to any of
                  the ingredients included in the tested formulations (Appendices 1 and 2)

               -  The subject received a topical or a systemic immune-modulator (such calcineurin
                  inhibitors or cortico-steroids) for the treatment of atopic dermatitis, within 14
                  days prior to day 0

               -  The subject underwent phototherapy within 28 days prior to day 0

               -  The subject is expected to be extensively exposed to the sun during the trial

               -  The subject underwent any experimental treatment within 14 days prior to day 0
No condition on gender to be admitted to the trial.
No healthy subjects accepted to join the trial.
Subject must be at least 2 Years old.
Subject must be at most 12 Years

Eligibility (NLI label): Entailment